Metabolism of new drug modalities research advances – 2023 year in review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metabolism of new drug modalities research advances – 2023 year in review

Published:2024-07-05 Issue: Volume: Page:1-24
ISSN:0360-2532
Container-title:Drug Metabolism Reviews
language:en
Short-container-title:Drug Metabolism Reviews

Author:

Ma Bin¹^ORCID,Argikar Upendra A²^ORCID,Cheruzel Lionel¹^ORCID,Cho Sungjoon¹^ORCID,Hauri Simon³^ORCID,Johnson Kevin M⁴^ORCID,Liu Joyce¹^ORCID,Schadt Simone³^ORCID,Wang Shuai¹^ORCID,Khojasteh S. Cyrus¹^ORCID

Affiliation:

1. Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USA

2. Non-clinical Development, Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA

3. Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland

4. Drug Metabolism and Pharmacokinetics, Inotiv, Maryland Heights, MO, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03602532.2024.2370331

Reference62 articles.

1. Biotransformation and bioactivation reactions – 2015 literature highlights

2. Advancing New Chemical Modalities into Clinical Studies

3. Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update

4. Putting peptides on display

5. Biotransformation research advances – 2022 year in review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP